Clinical Trial Update: Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib

View source ↗

Summary

Pfizer is reporting a clinical trial update on ritlecitinib for Alopecia Areata, describing the characterization and clinical outcomes observed in treated patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Ritlecitinib (ritlecitinib)

Snippet

Sponsor: Pfizer | Conditions: Alopecia Areata | Status: RECRUITING